Search by Drug Name or NDC
NDC 51672-4133-02 Lamotrigine 200 mg/1 Details
Lamotrigine 200 mg/1
Lamotrigine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., Inc.. The primary component is LAMOTRIGINE.
Product Information
| NDC | 51672-4133 |
|---|---|
| Product ID | 51672-4133_d589a030-fb7b-4957-b543-8dafba6104ba |
| Associated GPIs | 72600040000340 |
| GCN Sequence Number | 022551 |
| GCN Sequence Number Description | lamotrigine TABLET 200 MG ORAL |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 64325 |
| HICL Sequence Number | 007378 |
| HICL Sequence Number Description | LAMOTRIGINE |
| Brand/Generic | Generic |
| Proprietary Name | Lamotrigine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lamotrigine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | LAMOTRIGINE |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Pharmaceutical Class | Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078525 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51672-4133-02 (51672413302)
| NDC Package Code | 51672-4133-2 |
|---|---|
| Billing NDC | 51672413302 |
| Package | 500 TABLET in 1 BOTTLE (51672-4133-2) |
| Marketing Start Date | 2022-10-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |